menu icon

Investment

down-icon
image
Invest in the world’s largest market with US Stocks

Features

down-icon
support-icon
Pro Tools for Pro Traders
Uncover the powerful trading features

Pro Features

icon
support-icon
Built for Investors
Experience investing with simplified features

Pockets

icon

Fees

Safety

Academy

down-icon

More

down-icon
support-icon
Support

About Us

arrow-icon

Pluang+

|

assetIcon

BridgeBio Pharma Inc (BBIO) Stock Price Today

24H
1W
1M
3M
YTD
1Y
ALL

Overview

Financial

Technicals

Analysis

Corporate Action

About

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.


Technical Indicators

|

|

|

Overall Summary

Bearish (11)

Neutral (10)

Bullish (6)


Performance

BBIO ROI

arrow
+40.53%

% from 52W High

-6.28%
$35.23

52W Low: $22.35

18 Nov 2024

52W High: $37.59

24 Jan 2025


News

Pluang News
Pluang News

Benzinga

7mo

BridgeBio Pharma Seeks Partner To Develop Gene Therapy For Inherited Condition



People Also Bought

Pluang
Pluang
XYZ
Block Inc
+2.45%

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions



Let’s trade or invest in this asset by signing up or logging in!

register_card

Let’s trade or invest in this asset by signing up or logging in!

You can also download our app!

item